First-in-human, first choice
Australia is a leading destination for healthy volunteer and first-in-human studies. Avion CRO makes it work.
01
Speed, quality and cost in one place
Healthy volunteer and first-in-human studies are where the Australian advantage is strongest: faster regulatory start-up, an efficient ethics pathway, and a materially lower net cost of running the study. Avion CRO is the on-the-ground partner that turns those advantages into a running trial.
02
Recruitment and early-phase sites
Sponsors access healthy volunteer recruitment and experienced early-phase sites through Avion CRO’s established network, so first-participant timelines are grounded in reality rather than optimism.
03
Safety and scientific rigour
First-in-human decisions deserve senior eyes. Avion CRO’s senior team provides hands-on oversight of dose escalation and early study decisions, so safety and scientific judgement lead every step.
04
The start of something longer
A healthy volunteer study is rarely the end of the road. Early-phase data generated in Australia feeds directly into later-phase programmes anywhere in the world, and with Avion CRO the partner who ran your first study can run your next one too.
Common Questions
Because the Australian advantage is strongest at this stage: the CTN scheme starts studies sooner than a US IND pathway, ethics review is efficient, and the net cost of running the study is materially lower once the R&D tax offset is applied.
Faster than comparable US or European pathways, thanks to notification-based regulation and efficient ethics review.